title: Development of pseudogout during etanercept treatment.
authors.affiliation: University Program in Rheumatology, La Plata University, La Plata, Buenos Aires, Argentina. josefinamarcos@hotmail.com
authors.forename: Marcos
authors.initials: M
authors.lastname: Josefina
authors.forename: Cuneo Julia
authors.initials: CJ
authors.lastname: Ana
authors.forename: Vulcano
authors.initials: V
authors.lastname: Ariel
authors.forename: Arturi Alfredo
authors.initials: AA
authors.lastname: Silvio
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002805:Chondrocalcinosis / Q000139:chemically induced*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept